You are on the International Aridol Site. US residents select United States.
Welcome to the New Zealand homepage
The mannitol challenge test (Aridol®) is an indirect osmotic bronchial challenge test that can be used to identify bronchial hyperresponsivesness, a key clinical feature of respiratory conditions such as asthma.
Aridol is manufactured by Pharmaxis Ltd (Frenchs Forest, Sydney Australia) and is available as a standardised test kit containing pre-filled mannitol capsules and a hand held dry powder inhaler.
During a mannitol challenge test, the subject inhales increasing doses of mannitol with their lung function (forced expiratory volume in one second- FEV1) measured after each dose to determine the level of bronchial hyperresponsiveness.
The mannitol challenge test should only be performed by a suitably trained healthcare professional. Please refer to the approved product information or summary of product characteristics for your country prior to performing this challenge test.
Please note that in New Zealand a marketing application for Aridol has not been submitted.
For more information about Aridol in New Zealand please contact;
20 Rodborough Rd
NSW 2086, AUSTRALIA
Customer Support Line : +61 2 9454 7200
Fax: +61 2 9451 3622